Arrowhead Pharmaceuticals (ARWR) Times Interest Earned (2022 - 2025)
Historic Times Interest Earned for Arrowhead Pharmaceuticals (ARWR) over the last 4 years, with Q4 2025 value amounting to $1.81.
- Arrowhead Pharmaceuticals' Times Interest Earned rose 12431.75% to $1.81 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.33, marking a year-over-year increase of 12588.3%. This contributed to the annual value of $1.1 for FY2025, which is 10592.35% up from last year.
- As of Q4 2025, Arrowhead Pharmaceuticals' Times Interest Earned stood at $1.81, which was up 12431.75% from $2.03 recorded in Q3 2025.
- Arrowhead Pharmaceuticals' 5-year Times Interest Earned high stood at $17.62 for Q1 2025, and its period low was -$34.58 during Q2 2024.
- For the 4-year period, Arrowhead Pharmaceuticals' Times Interest Earned averaged around -$9.77, with its median value being -$11.07 (2024).
- Per our database at Business Quant, Arrowhead Pharmaceuticals' Times Interest Earned tumbled by 28289.9% in 2024 and then skyrocketed by 20112.72% in 2025.
- Quarter analysis of 4 years shows Arrowhead Pharmaceuticals' Times Interest Earned stood at -$14.79 in 2022, then tumbled by 72.03% to -$25.44 in 2023, then surged by 70.69% to -$7.46 in 2024, then skyrocketed by 124.32% to $1.81 in 2025.
- Its last three reported values are $1.81 in Q4 2025, $2.03 for Q3 2025, and -$6.79 during Q2 2025.